PyInvesting

Market research

LIXT Lixte Biotechnology Holdings Inc

PINK USD Industrials

Latest close

4.42 —

As of 27 Aug 2026

Test a moving-average rule with historical data.

Market facts
Market cap
125M
P/E ratio
Not available
Analyst target
Not available
Dividend yield
Not available
Beta
1.25

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 7 months ago

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.

Based on the above factors, Lixte Biotechnology Holdings, Inc gets an overall score of 1/5.